| 1-R15-EB035866-01 |
Mitochondrial-targeting Exosomes for Neuroinflammation |
Lanrong Bi |
Michigan Technological University |
| 5-R21-EB034346-02 |
Next generation of delivery platform for Prime editors based on an RNA vector for Sickle cell disease: the “all-in-one” vector |
Patricia Devaux |
Mayo Clinic Rochester |
| 1-R01-EB036493-01 |
Non-invasive and Long-lived CNS Delivery of Treg-inducing Cytokine Depots |
Peter Tessier |
University of Michigan at Ann Arbor |
| 5-R21-EB035261-02 |
Programmable 'all-in-one' RNA as a molecular scaffold for targeted combinatorial innate immune activation |
Connie Wu |
University of Michigan at Ann Arbor |
| 5-R21-EB033981-03 |
Readthrough of disease-causing nonsense mutations by targeted selenocysteine recoding |
Oded Regev |
New York University |
| 5-R01-EB031830-04 |
Reprogramming Exosomes for Biomedical Applications |
Yong Zhang |
University of Southern California |
| 5-R21-EB036277-02 |
Ribozyme-mediated killing of cells harboring cancer driver mutations |
André Leier |
University of Alabama at Birmingham |
| 1-R01-EB031936-01 |
Semi-synthetic, magneto-photonic circuit for non-invasive control of cellular function |
Ute Hochgeschwender |
Central Michigan University |
| 5-R01-EB029483-06 |
Synthetic circuit technologies for precision control and signal processing in mammalian cells |
Ahmad Khalil |
Boston University (Charles River Campus) |
| 1-R01-EB037025-01 |
Synthetic RNA Switch-Based Temporal and Dose Control of in Vivo Gene Therapies |
Guocai Zhong |
Univ of Massachusetts Med Sch Worcester |
